Satoko Kishimoto Selected Research

Satoko Kishimoto Research Topics

Disease

12	Wounds and Injuries (Trauma) 01/2020 - 07/2007
6	Ischemia 01/2020 - 09/2011
3	Neoplasms (Cancer) 07/2019 - 08/2017
2	Stress Urinary Incontinence 10/2022 - 06/2018
2	Hypoxia (Hypoxemia) 07/2019 - 08/2012
2	Peripheral Arterial Disease 01/2013 - 09/2011
2	Chronic Limb-Threatening Ischemia 01/2013 - 09/2011
2	Hemorrhage 04/2012 - 04/2010
1	Atrial Fibrillation 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Atherosclerosis 01/2023
1	Vascular System Injuries 01/2023
1	Squamous Cell Carcinoma of Head and Neck 12/2022
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Carcinoma (Carcinomatosis) 10/2018
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2013
1	Synostosis 09/2013
1	Shock 08/2012
1	Skin Ulcer 01/2012
1	Infections 10/2008
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2008

Drug/Important Bio-Agent (IBA)

5	ChitosanIBA 09/2013 - 01/2010
4	HydrogelsIBA 09/2013 - 01/2010
3	Protamines (Protamine Sulfate)FDA Link 01/2016 - 09/2011
3	Proteins (Proteins, Gene)FDA Link 01/2013 - 10/2008
3	fucoidanIBA 01/2012 - 01/2010
3	AlginatesIBA 01/2012 - 01/2010
3	ChitinIBA 01/2012 - 01/2010
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 09/2010 - 07/2007
2	Dalteparin (Dalteparin Sodium)FDA Link 01/2013 - 09/2011
2	SolutionsIBA 12/2012 - 01/2010
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2012 - 09/2011
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2011 - 10/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2011 - 03/2009
2	atelocollagenIBA 01/2011 - 07/2007
1	Factor Xa InhibitorsIBA 01/2023
1	erucylphosphocholineIBA 01/2023
1	RivaroxabanIBA 01/2023
1	AnticoagulantsIBA 01/2023
1	Warfarin (Coumadin)FDA LinkGeneric 01/2023
1	antineoplaston A10 (A 10)IBA 12/2022
1	AnnexinsIBA 12/2022
1	Fluorouracil (Carac)FDA LinkGeneric 07/2019
1	Cisplatin (Platino)FDA LinkGeneric 07/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019
1	Tissue Adhesives (Tissue Adhesive)IBA 04/2019
1	Peptide Hydrolases (Proteases)FDA Link 10/2018
1	Matrix Metalloproteinases (MMPs)IBA 10/2018
1	Thymidine KinaseIBA 08/2017
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2016
1	Phosphates (Orthophosphate)IBA 01/2013
1	SuspensionsIBA 11/2012
1	Fatty Acid-Binding ProteinsIBA 08/2012
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 08/2012
1	Epinephrine (Adrenaline)FDA LinkGeneric 08/2012
1	CatecholaminesIBA 08/2012
1	liposome-encapsulated hemoglobinIBA 08/2012
1	Hypertonic Saline SolutionIBA 04/2012
1	Colloids (Colloid)IBA 01/2012
1	tachocombIBA 04/2010
1	PowdersIBA 01/2010
1	CytokinesIBA 03/2009
1	Heparin (Liquaemin)FDA LinkGeneric 10/2008
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2008
1	Polystyrenes (Polystyrene)IBA 10/2008
1	Collagen Type I (Type I Collagen)IBA 10/2008
1	SiliconesIBA 07/2007

Therapy/Procedure

3	Transplantation 06/2018 - 07/2007
2	Therapeutics 01/2013 - 09/2011
2	Injections 12/2012 - 11/2012
2	Intramuscular Injections 12/2012 - 11/2012
1	Percutaneous Coronary Intervention 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2022
1	Operative Surgical Procedures 01/2020
1	Heterotopic Transplantation 06/2018
1	Ligation 01/2016
1	Hemodilution 08/2012
1	Hair Removal (Depilation) 01/2012
1	Aftercare (After-Treatment) 03/2009